Medicare Will Pick Drugs For Negotiation Based On Gross Sales, Disadvantaging Highly-Rebated Products

 
• By Cathy Kelly

But on the bright side, knowing that eligibility will not be based on net sales to Medicare makes it easier to predict which drugs will be selected first.

Rebates Won't Protect Costly Drugs From 'Negotiated' Price Cuts • Source: Shutterstock

More from Market Access

More from Pink Sheet